WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹1.60 Cr | ₹3.12 Cr | ₹-15 Cr | ₹-7.97 Cr | ₹5.22 Cr |
What is the latest Net Cash Inflow / Outflow ratio of WINDLAS BIOTECH ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹1.60 Cr |
Mar2023 | ₹3.12 Cr |
Mar2022 | ₹-15 Cr |
Mar2021 | ₹-7.97 Cr |
Mar2020 | ₹5.22 Cr |
How is Net Cash Inflow / Outflow of WINDLAS BIOTECH Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹1.60 Cr | -48.59 | |
Mar2023 | ₹3.12 Cr | Positive | |
Mar2022 | ₹-15 Cr | Negative | |
Mar2021 | ₹-7.97 Cr | Negative | |
Mar2020 | ₹5.22 Cr | - |
Compare Net Cash Inflow / Outflow of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹1,906.6 Cr | 1.6% | -1.8% | 23.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,788.0 Cr | 0.5% | 0.6% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,283.0 Cr | 3.7% | 5.1% | 49.1% | Stock Analytics | |
CIPLA | ₹121,853.0 Cr | -1% | 1.7% | 2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,914.0 Cr | 3.8% | 6.8% | 22.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,932.0 Cr | -3.7% | 1.9% | -0.3% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | 1.6% |
-1.8% |
23.8% |
SENSEX | 0.8% |
2.5% |
5.3% |
You may also like the below Video Courses